Advancing Global Health with Hepatitis A Vaccine

2026 07/29

We are proud to highlight our Hepatitis A (Live) Vaccine, Freeze-dried, a vital tool in preventing hepatitis A worldwide. Manufactured using a highly stable, attenuated virus strain cultured in human diploid cells, this vaccine is rigorously purified to ensure exceptional safety and efficacy.

 

Clinical data demonstrates that a single dose stimulates robust and long-lasting immune responses in both children and adults, with an excellent safety profile and minimal adverse reactions. Its advanced freeze-dried formulation guarantees superior stability for convenient storage and transport.

 

Committed to "quality first and innovation," we continue to supply high-standard vaccines to domestic and international markets, dedicated to protecting public health and advancing global disease prevention efforts.